Posted on June 21st, 2021. Posted by Tom McDonald
There’s a saying in investor relations: “You date your investment bankers, but you marry your research analysts.” Essentially, this means that most sell-side analysts who cover your company will remain your partner for the long run. Investment bankers, on the other hand, work with a long list of companies and deal with jam-packed, demanding schedules. They don’t disappear after the initial public offering (IPO), but the time they can devote to your company diminishes.
Continue Reading
Posted on June 9th, 2021. Posted by Patti Bank
A well-planned and executed research and development (R&D) day can reinforce a company’s message, heighten a company’s visibility, and allow a management team to highlight their investment thesis. It can be an effective and efficient investor relations tool if done correctly.
Continue Reading
Posted on May 20th, 2021. Posted by Tom McDonald
Special purpose acquisition company (SPAC) activity has exploded in the past two years, from 59 transactions in 2019, to 248 deals in 2020, to 308 SPACs so far in 2021. However, SPACs are not new. This type of transaction has been around for decades, continually evolving as it rises and falls in popularity.
Continue Reading
Posted on May 6th, 2021. Posted by Lee Stetner
Going public is a transformational event that gives companies the capital they need to invest in future growth, attract top talent, and raise their profile, while providing liquidity to investors and employees.
Continue Reading
Posted on April 22nd, 2021. Posted by Tom McDonald
Unlike quiet periods following an IPO, which are closely regulated by the Securities and Exchange Commission (SEC), end-of-quarter quiet periods are more loosely defined and not strictly regulated.
Continue Reading
Posted on April 8th, 2021. Posted by Bob East
Right after you report earnings is the ideal time to get out on the road and tell your story to the Street. Sell-side analysts are incentivized to market with management teams, so they are always willing to sponsor a non-deal road show (NDRS).
Continue Reading
Posted on March 18th, 2021. Posted by Mike Vallie
In 2018, we wrote a piece on best practices to manage and communicate with the growing retail investor community. While the basic tenants of those recommendations hold today, the retail investor has fundamentally changed over the last couple of years.
Continue Reading
Posted on March 4th, 2021. Posted by Tom McDonald
One of our clients, a recently public diagnostics company, settled an ongoing royalty dispute with a major pharmaceutical company. The settlement amount was significantly lower than what our client had accrued, resulting in nearly $750 thousand upside to their P&L in the upcoming quarter.
Continue Reading
Posted on February 23rd, 2021. Posted by Tom McDonald
No one would argue that 2020 was unique and challenging for almost every industry, including healthcare. The year forced both public and private companies to reconsider many aspects of how they do business and communicate with the investment community. As we all adapted and learned, our Westwicke blog covered a variety of investor relations topics, both pandemic related and not. Below are some of the most popular blog posts we published this year.
Continue Reading
Posted on February 10th, 2021. Posted by Mike Piccinino, CFA
Many public companies withdrew, or never introduced, formal financial guidance in spring 2020 as a result of severe and widespread business disruption and the high level of uncertainty surrounding the COVID-19 pandemic. We are now roughly two weeks into the fourth quarter and fiscal year 2020 earnings reporting season and wanted to share a few notable trends and key considerations that public company management teams should bear in mind as they evaluate whether to give formal financial guidance for 2021.
Continue Reading
